Capital/Financing Update • Jun 21, 2023
Capital/Financing Update
Open in ViewerOpens in native device viewer

Puteaux, 21 June 2023 (9:00 pm CEST)
The shareholders are informed of the publication of the addendum of 21 June 2023 to the report dated 24 May 2023 of SORGEM Evaluation, which acted as an independent expert with the task of giving an opinion, in accordance with Article 261-3 of the Règlement Général of the Autorité des marchés financiers, on the fairness of the proposed financial restructuring of the Company for the shareholders of the Company.
The addendum to the independent expert's report is available to shareholders in full on the Company's website (link) and at the Company's registered office.
The conclusions of the addendum to the SORGEM Evaluation report are as follows: "In light of the above, our conclusion as to the fairness of the restructuring plan to current shareholders, expressed in part VII of our report of 24 May 2023, remains unchanged following discussions with certain shareholders and creditors of the Group and after analysis of the comments submitted."


ORPEA is a leading global player, expert in providing care for all types of frailty. The Group operates in 21 countries and covers three core businesses: care for the elderly (nursing homes, assisted living facilities, homecare and services), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 76,000 employees and welcomes more than 267,000 patients and residents each year.
ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a member of the SBF 120 and CAC Mid 60 indices.
| Investor Relations | Investor Relations | Press Relations |
|---|---|---|
| ORPEA | NewCap | ORPEA |
| Benoit Lesieur | Dusan Oresansky | Isabelle Herrier-Naufle |
| Investor Relations Director | Tel.: 01 44 71 94 94 | Press Relations Director |
| [email protected] | [email protected] | Tel.: 07 70 29 53 74 |
Toll-free number for shareholders:
0 805 480 480
Image7
Charlotte Le Barbier // Laurence Heilbronn 06 78 37 27 60 - 06 89 87 61 37 [email protected] [email protected]

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.